Historical record - last NADAC publication: 2/22/2017
Product Information
HYDROCHLOROTHIAZIDE 12.5 MG CP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0444 per EA under NDC 65862011301. Its NADAC has been published 170 times since Nov 28, 2013.
Strength
12.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862011301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/22/2017
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078164On Market Since
9/19/2007
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0444 per EA |
|---|---|
| All-time high | $0.0731 (Feb 12, 2014) |
| All-time low | $0.0424 (Jan 18, 2017) |
| Median price | $0.0535 |
| Average price | $0.0549 |
| Largest weekly change | +20.3% (Dec 18, 2013) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG CP, manufactured by Aurobindo Pharma Limited, is $0.0444 per EA (NDC 65862011301), effective Feb 22, 2017.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG CP changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has declined 18.5%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG CP?
Since Nov 28, 2013, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has ranged from a low of $0.0424 (Jan 18, 2017) to a high of $0.0731 (Feb 12, 2014), with a median of $0.0535 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG CP?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCHLOROTHIAZIDE 12.5 MG CP, is $0.0284 per EA — about 36% below HYDROCHLOROTHIAZIDE 12.5 MG CP.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG CP?
HYDROCHLOROTHIAZIDE 12.5 MG CP (NDC 65862011301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification